Thromboembolic Complications in Patients with Clopidogrel Resistance after Coil Embolization for Unruptured Intracranial Aneurysms

REFERENCES

1. 1.↵
   1. Gurbel PA,
   2. Bliden KP,
   3. Hiatt BL,
   4. et al

   . Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity. Circulation 2003;107:2908–13

   Abstract/FREE Full Text
2. 2.↵
   1. Fifi JT,
   2. Brockington C,
   3. Narang J,
   4. et al

   . Clopidogrel resistance is associated with thromboembolic complications in patients undergoing neurovascular stenting. AJNR Am J Neuroradiol 2013;34:716–20

   Abstract/FREE Full Text
3. 3.↵
   1. Kang HS,
   2. Kwon BJ,
   3. Kim JE,
   4. et al

   . Preinterventional clopidogrel response variability for coil embolization of intracranial aneurysms: clinical implications. AJNR Am J Neuroradiol 2010;31:1206–10

   Abstract/FREE Full Text
4. 4.↵
   1. Delgado Almandoz JE,
   2. Kadkhodayan Y,
   3. Crandall BM,
   4. et al

   . Variability in initial response to standard clopidogrel therapy, delayed conversion to clopidogrel hyper-response, and associated thromboembolic and hemorrhagic complications in patients undergoing endovascular treatment of unruptured cerebral aneurysms. J Neurointerv Surg 2014 Jan 7. [Epub ahead of print]
5. 5.↵
   1. Cronqvist M,
   2. Wirestam R,
   3. Ramgren B,
   4. et al

   . Diffusion and perfusion MRI in patients with ruptured and unruptured intracranial aneurysms treated by endovascular coiling: complications, procedural results, MR findings and clinical outcome. Neuroradiology 2005;47:855–73

   CrossRefPubMedWeb of Science
6. 6.↵
   1. Altay T,
   2. Kang HI,
   3. Woo HH,
   4. et al

   . Thromboembolic events associated with endovascular treatment of cerebral aneurysms. J Neurointerv Surg 2011;3:147–50

   Abstract/FREE Full Text
7. 7.↵
   1. Pierot L,
   2. Spelle L,
   3. Vitry F,
   4. et al

   . Immediate clinical outcome of patients harboring unruptured intracranial aneurysms treated by endovascular approach: results of the ATENA study. Stroke 2008;39:2497–504

   Abstract/FREE Full Text
8. 8.↵
   1. Lee DH,
   2. Arat A,
   3. Morsi H,
   4. et al

   . Dual antiplatelet therapy monitoring for neurointerventional procedures using a point-of-care platelet function test: a single-center experience. AJNR Am J Neuroradiol 2008;29:1389–94

   Abstract/FREE Full Text
9. 9.↵
   1. Gurbel PA,
   2. Tantry US

   . Clopidogrel resistance? Thromb Res 2007;120:311–21

   CrossRefPubMedWeb of Science
10. 10.↵
    1. Delgado Almandoz JE,
    2. Crandall BM,
    3. Scholz JM,
    4. et al

    . Pre-procedure P2Y12 reaction units value predicts perioperative thromboembolic and hemorrhagic complications in patients with cerebral aneurysms treated with the Pipeline embolization device. J Neurointerv Surg 2013;5(suppl 3):iii3–10

    Abstract/FREE Full Text
11. 11.↵
    1. Maruyama H,
    2. Takeda H,
    3. Dembo T,
    4. et al

    . Clopidogrel resistance and the effect of combination cilostazol in patients with ischemic stroke or carotid artery stenting using the VerifyNow P2Y12 assay. Intern Med 2011;50:695–98

    CrossRefPubMed
12. 12.↵
    1. Jo KI,
    2. Yeon JY,
    3. Kim KH,
    4. et al

    . Predictors of thromboembolism during coil embolization in patients with unruptured intracranial aneurysm. Acta Neurochir (Wien) 2013;155:1101–06

    PubMed
13. 13.↵
    1. Brooks NP,
    2. Turk AS,
    3. Niemann DB,
    4. et al

    . Frequency of thromboembolic events associated with endovascular aneurysm treatment: retrospective case series. J Neurosurg 2008;108:1095–100

    CrossRefPubMedWeb of Science
14. 14.↵
    1. Adams HP Jr.,
    2. Bendixen BH,
    3. Kappelle LJ,
    4. et al

    . Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST–Trial of Org 10172 in acute stroke treatment. Stroke 1993;24:35–41

    Abstract/FREE Full Text
15. 15.↵
    1. Workman MJ,
    2. Cloft HJ,
    3. Tong FC,
    4. et al

    . Thrombus formation at the neck of cerebral aneurysms during treatment with Guglielmi detachable coils. AJNR Am J Neuroradiol 2002;23:1568–76

    Abstract/FREE Full Text
16. 16.↵
    1. Delgado Almandoz JE,
    2. Crandall BM,
    3. Scholz JM,
    4. et al

    . Last-recorded P2Y12 reaction units value is strongly associated with thromboembolic and hemorrhagic complications occurring up to 6 months after treatment in patients with cerebral aneurysms treated with the Pipeline embolization device. AJNR Am J Neuroradiol 2014;35:128–35

    Abstract/FREE Full Text
17. 17.↵
    1. Bendszus M,
    2. Stoll G

    . Silent cerebral ischaemia: hidden fingerprints of invasive medical procedures. Lancet Neurol 2006;5:364–72

    CrossRefPubMedWeb of Science
18. 18.↵
    1. Knipp SC,
    2. Matatko N,
    3. Wilhelm H,
    4. et al

    . Evaluation of brain injury after coronary artery bypass grafting. A prospective study using neuropsychological assessment and diffusion-weighted magnetic resonance imaging. Eur J Cardiothorac Surg 2004;25:791–800

    Abstract/FREE Full Text
19. 19.↵
    1. Restrepo L,
    2. Wityk RJ,
    3. Grega MA,
    4. et al

    . Diffusion- and perfusion-weighted magnetic resonance imaging of the brain before and after coronary artery bypass grafting surgery. Stroke 2002;33:2909–15

    Abstract/FREE Full Text
20. 20.↵
    1. Rordorf G,
    2. Bellon RJ,
    3. Budzik RE Jr..,
    4. et al

    . Silent thromboembolic events associated with the treatment of unruptured cerebral aneurysms by use of Guglielmi detachable coils: prospective study applying diffusion-weighted imaging. AJNR Am J Neuroradiol 2001;22:5–10

    Abstract/FREE Full Text
21. 21.↵
    1. van Rooij WJ,
    2. Sluzewski M,
    3. Beute GN,
    4. et al

    . Procedural complications of coiling of ruptured intracranial aneurysms: incidence and risk factors in a consecutive series of 681 patients. AJNR Am J Neuroradiol 2006;27:1498–501

    Abstract/FREE Full Text
22. 22.↵
    1. Kang DH,
    2. Kim BM,
    3. Kim DJ,
    4. et al

    . MR-DWI-positive lesions and symptomatic ischemic complications after coiling of unruptured intracranial aneurysms. Stroke 2013;44:789–91

    Abstract/FREE Full Text
23. 23.↵
    1. Hu YC,
    2. Deshmukh VR,
    3. Albuquerque FC,
    4. et al

    . Histopathological assessment of fatal ipsilateral intraparenchymal hemorrhages after the treatment of supraclinoid aneurysms with the Pipeline embolization device. J Neurosurg 2014;120:365–74

    PubMedWeb of Science
24. 24.↵
    1. Kim BJ,
    2. Lee SW,
    3. Park SW,
    4. et al

    . Insufficient platelet inhibition is related to silent embolic cerebral infarctions after coronary angiography. Stroke 2012;43:727–32

    Abstract/FREE Full Text
25. 25.↵
    1. Busing KA,
    2. Schulte-Sasse C,
    3. Fluchter S,
    4. et al

    . Cerebral infarction: incidence and risk factors after diagnostic and interventional cardiac catheterization–prospective evaluation at diffusion-weighted MR imaging. Radiology 2005;235:177–83

    CrossRefPubMedWeb of Science
26. 26.↵
    1. Brockmann C,
    2. Hoefer T,
    3. Diepers M,
    4. et al

    . Abciximab does not prevent ischemic lesions related to cerebral angiography: a randomized placebo-controlled trial. Cerebrovasc Dis 2011;31:353–57

    CrossRefPubMed
27. 27.↵
    1. Albayram S,
    2. Selcuk H,
    3. Kara B,
    4. et al

    . Thromboembolic events associated with balloon-assisted coil embolization: evaluation with diffusion-weighted MR imaging. AJNR Am J Neuroradiol 2004;25:1768–77

    Abstract/FREE Full Text
28. 28.↵
    1. Qureshi AI,
    2. Mohammad Y,
    3. Yahia AM,
    4. et al

    . Ischemic events associated with unruptured intracranial aneurysms: multicenter clinical study and review of the literature. Neurosurgery 2000;46:282–89; discussion 89–90

    CrossRefPubMedWeb of Science